Jones Trevor Nauseef, M.D., Ph.D.
Provider of world-class care at NewYork-Presbyterian
Locations and Appointments
Please contact the doctor's office to verify that your insurance is accepted.
- Blue Access
- Blue Connection
- Mediblue (Senior)
- Medicare Advantage
- Community Plan
About Jones Trevor Nauseef, M.D., Ph.D.
Growing up in a household headed by a physician-scientist father and an artist mother in the Iowa countryside instilled in me the importance of intellectual pursuit, compassion, humanity, and hard work. My path to oncology has incorporated combined training in liberal arts, molecular physiology and biophysics, and medicine. An intrinsic curiosity about cancer as well as the strong relationships established between patients with cancer and their treating doctor led me to become an oncologist. As a medical oncologist, I specialize in caring for people with genitourinary (GU) cancers in addition to patients enrolled in early phase clinical trials. I am actively engaged in advancing our understanding of these cancers through translational research efforts incorporating genomics. My priority is to deliver compassionate, patient-focused, and precision care for all of my patients. It is the combination of these patient interactions and scientific discovery that perpetually feed my enthusiasm for oncology and hope for a continually brighter tomorrow for all cancer patients.
Jones Nauseef, M.D., Ph.D., is an Assistant Professor of Medicine within the Division of Hematology and Medical Oncology at Weill Cornell Medicine, and Assistant Attending physician at NewYork-Presbyterian Hospital. His clinical emphasis is on Genitourinary (GU) cancers and Phase I clinical trials. His research is focused on genomics of advanced prostate cancers, including neuroendocrine prostate cancer, as well as health care disparities.
Dr. Nauseef received his B.A. in Biology in 2006 from Swarthmore College, where he also participated in NCAA Track and Cross Country. In 2015, Dr. Nauseef earned his M.D. and Ph.D. in Molecular Physiology and Biophysics (Laboratory of Dr. Michael D. Henry) as part of the NIH-sponsored MedicalScientist Training Program (MSTP) at the Carver College of Medicine of theUniversity of Iowa. He continued his medical training at Weill Cornell Medicine and NewYork-Presbyterian (WCM/NYP), where he completed his Internship and Residency in Internal Medicine in 2018. He was honored to be the recipient of the David B. Skinner award at the conclusion of his residency. He remained at WCM/NYP for his Fellowship in Hematology and Medical Oncology, during which time he was awarded a 2020 Conquer Cancer Foundation of ASCO Young Investigator Award (YIA) and the 2021 Scott Wadler Fellows Clinical Research Award. During his Fellowship, Dr. Nauseef expanded his research focus to include the genomics of advanced prostate cancers and health care disparities in American men of African descent. He serves as co-investigator or collaborator on extramural grants for the latter project. Dr. Nauseef will continue these investigations as a member of the Englander Institute for Precision Medicine and inaffiliation with the New York Genome Center, with the primary goal of leveraging discoveries to develop clinical trials as part of the Phase I/Earlytherapeutics group at Weill Cornell’s Meyer Cancer Center.
2020 Conquer Cancer Foundation ASCO Young Investigator Award Recipient
2021 Scott Wadler Fellows Clinical Research Award
M.D., Ph.D.University of Iowa College of Medicine2015
Assistant Attending PhysicianNewYork-Presbyterian Hospital
Assistant Professor of MedicineWeill Cornell Medical College, Cornell University
News & Media
Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.